Who received the Laser-Debakey Clinical Medical Research Aware?
In April 1994, the results of a Merck-sponsored study, the Scandinavian Simvastatin Survival Study, were announced. Researchers tested simvastatin, later sold by Merck as Zocor, on 4,444 patients with high cholesterol and heart disease. After five years, the study concluded the patients saw a 35% reduction in their cholesterol, and their chances of dying of a heart attack were reduced by 42%. In 1995, Zocor and Mevacor both made Merck over US$1 billion. Endo was awarded the 2006 Japan Prize, and the Lasker-DeBakey Clinical Medical Research Award in 2008. For his "pioneering research into a new class of molecules" for "lowering cholesterol,"[sentence fragment]
A second biotechnology district is being planned for the median strip on Frontage Road, on land cleared for the never-built Route 34 extension. As of late 2009, a Pfizer drug-testing clinic, a medical laboratory building serving Yale – New Haven Hospital, and a mixed-use structure containing parking, housing and office space, have been constructed on this corridor. A former SNET telephone building at 300 George Street is being converted into lab space, and has been so far quite successful in attracting biotechnology and medical firms.